Firming sheet-mask MK-3107 — private label formula

What is this formulation?

Key actives

乙酰基六肽-8 · 棕榈酰五肽-4 · 麦角硫因

Texture

天丝膜布配高留液量，精华微稠带丝滑拉感，敷后剩余液可直接按摩至吸收，不返黏。

Markets

CN,US,EU,KR

Cost band

Mid

Route to market by destination

China: general cosmetic · filing
上市路径按目的地市场走,以下为通用口径,均以各国最新官方文本为准,具体申报由品牌方与其当地责任人负责。【中国】普通化妆品向 NMPA 备案,需提交全成分、执行标准、标签样稿与安全评估资料。【欧盟】按 EC No 1223/2009 在 CPNP 通报,须有欧盟境内责任人(RP)与安全评估报告(CPSR),并建立产品信息档案(PIF)。【美国】按 MoCRA 完成设施注册与产品列名,并留存安全性证实资料;彩妆与护肤按化妆品路径。【东盟】按 ACD 指令通报;印尼/泰国/马来西亚/越南/菲律宾/新加坡的系统与账号资质差异很大,都必须绑定当地法人主体 —— 详见站内「东南亚六国通报账号门槛与办理路径」。【日本】按用途区分化粧品与医薬部外品,后者走承认申请。【中东与海湾】按目的地(如沙特 SFDA)注册;清真认证按客户市场要求配套。

Regulatory note

中国按普通化妆品备案，所用多肽须在已使用原料目录内，超目录需先走新原料注册备案通道；欧盟 CPNP 通报并保留完整 PIF。

How is it processed?

Ranges are given per format, not per SKU — a single number would be false precision. The sampling report governs.

Shelf life

24 months

Key actives in market inventories

• 乙酰基六肽-8 Acetyl Hexapeptide-8
  • 中国 · Inventory of Existing Cosmetic Ingredients in China (2021) 07780
• 棕榈酰五肽-4 Palmitoyl Pentapeptide-4
  • 中国 · Inventory of Existing Cosmetic Ingredients in China (2021) 08759
• 麦角硫因 Ergothioneine
  • 中国 · Inventory of Existing Cosmetic Ingredients in China (2021) 04576
  • 欧盟 · CosIng — European Commission cosmetic ingredient database 56156 · 功能 ANTIOXIDANT, SKIN CONDITIONING - MISCELLANEOUS

Exact INCI match; only listed registries are shown. Absence from a restricted list is not the same as unrestricted.

pH range

On enquiry

Viscosity

On enquiry

Filling temperature

On enquiry

Preservative system

On enquiry

The full process window — pH, viscosity, filling temperature, preservative system and active dosage ranges — comes with the sampling pack. It is the formulator’s work, not marketing copy, so it is not published. Send an enquiry, or ask for a WhatsApp / WeChat callback and we will send the full specification and a quote for your market and format.Request the full specification

Which packaging fits?

Commonly paired with this format. Quote the packaging code back to us.

• AL-002-5airless-bottle · 100ml/120ml/150ml · PET
• AL-003-1airless-bottle · 150ml/200ml/300ml · PET
• AL-003-5airless-bottle · 150ml/200ml/300ml · PET
• AL-003-7airless-bottle · 150ml/200ml/300ml · PET

Why does the market support this direction?

Every signal carries a source and a date.

• Peptide therapy buzz drives a wave of peptide serum launches, led by GHK-Cu 「peptide therapy」谷歌搜索同比 +281%(TikTok +459%、Instagram +412%)Glossy(数据来自 Spate) · 2026-04-20

Frequently asked

• Can the formula be changed?

  Yes. Actives, concentrations, texture and fragrance can be adjusted to your positioning; changes require fresh stability and compatibility testing, and the timeline is confirmed at sampling.

• Is the MOQ negotiable?

  It can be discussed. MOQ is set by the highest of three limits: the minimum controllable batch on the line, the packaging supplier MOQ, and changeover amortisation. Tell us your first-run plan and we will give a workable floor.

• Can I add my own ingredient?

  Yes. We need the supplier technical file (solubility, pH window, addition temperature, microbial status) and safety information; we assess compatibility before scheduling a sample.

• Can packaging colour and finish change?

  Yes — silkscreen, hot stamping, spraying and labelling are all available. We do not commit to numeric colour tolerance on metallics and pearlescents; an approved physical sample governs.

• Can I put my own brand on it?

  Yes, that is the normal contract-manufacturing arrangement. Label content must be reviewed against your target market rules; we provide the factory-side documents, and the compliance conclusion is issued by the brand and its responsible person.